Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin.
Diamantstein T, Volk HD, Tilney NL, Kupiec-Weglinski J. Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin. Immunobiology. 1986 Sep; 172(3-5):391-9.